
Inflammation and cell proliferation signatures: Implications for response to immune checkpoint inhibition therapies
by Christina Black | Jun 19, 2020
View the published publication
Tumor inflammatory signature as a biomarker of response to immunotherapy in lung cancer
by Christina Black | Jun 19, 2020
View the published articleFollow Us on Twitter
This December, Dr. Sarabjot Pabla joins the speaker lineup for the TIGIT Axis Therapies Digital Summit. His presentation will focus on TIGIT RNA expressions and their impact in precision oncology medicines. Register for the virtual event today: https://bit.ly/3NAKg3S
LABCORP EXPANDS ACCESS TO COMPREHENSIVE GENOMIC TESTING THROUGH NEW LUNG CANCER PROGRAM UTILIZING OmniSeq INSIGHT
https://tinyurl.com/59xf82c6
@OmniSeq
@Labcorp
#oncology
#precisionmedicine